Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial.

CT DLBCL FDG artificial intelligence tumor location

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
07 Dec 2023
Historique:
received: 12 07 2023
revised: 23 10 2023
medline: 10 12 2023
pubmed: 10 12 2023
entrez: 10 12 2023
Statut: aheadofprint

Résumé

Baseline [

Identifiants

pubmed: 38071535
pii: jnumed.123.266322
doi: 10.2967/jnumed.123.266322
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Kibrom B Girum (KB)

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France.

Anne-Ségolène Cottereau (AS)

Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.

Laetitia Vercellino (L)

Department of Nuclear Medicine, Saint Louis Hospital, AP-HP, Paris, France.

Louis Rebaud (L)

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France.
Research and Clinical Collaborations, Siemens Medical Solutions USA, Knoxville, Tennessee.

Jérôme Clerc (J)

Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.

Olivier Casasnovas (O)

Department of Hematology, University Hospital of Dijon, Dijon, France.

Franck Morschhauser (F)

Research Group on Injectable Forms and Associated Technologies, Department of Hematology, Claude Huriez Hospital, University Lille, Lille, France; and.

Catherine Thieblemont (C)

Department of Hematology, Saint Louis Hospital, AP-HP, Paris, France.

Irène Buvat (I)

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France; irene.buvat@curie.fr.

Classifications MeSH